Tonic-Clonic Seizures Treatment Market Trends There is a growing trend towards the use of combination therapies to manage tonic-clonic seizures. Combining multiple anti-seizure medications or ...

The Key Tonic clonic Seizure Companiesin theamrket include - Emory University, Pfizer, GlaxoSmithKline, Eisai Inc., Xenon Pharmaceuticals, UCB Pharma, Johnson ...

This page lists all known medications that could potentially lead to 'Tonic-clonic seizures' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Eisai announced results from a Phase 3 Study 332 trial of perampanel, an AMPA receptor antagonist in patients with primary generalized tonic-clonic (PGTC) seizures. Study 332 was a double-blind, ...

Sudden unexpected death in epilepsy (SUDEP) is a leading cause of premature death, affecting 1·00–1·14 per 1000 people with epilepsy annually.1 Identifying those at high risk or low risk of SUDEP is ...

-- New approval for VIMPAT® (lacosamide) CV in the U.S. as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures (PGTCS) in patients four years of age and older -- All three ...

WASHINGTON -- Technologies to provide instant at-home detection of life-threatening seizures and that could allow epilepsy patients to monitor their own drug levels are on the horizon, researchers ...

FINTEPLA is approved by the U.S. Food and Drug Administration (FDA) for the treatment of seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients two years of age and older 1 ...

Researchers have discovered supplementing a normal, carbohydrate-rich diet with specific ketogenic agents may significantly delay tonic-clonic seizures caused by exposure to high levels of oxygen. The ...